Stockscreener 앱 받기
1.46
5.81%
-0.09
시장 영업 전:
1.45
-0.01
-0.68%
전일 마감가:
$1.55
열려 있는:
$1.54
하루 거래량:
673.07K
Relative Volume:
0.26
시가총액:
$4.14M
수익:
-
순이익/손실:
$-8.85M
주가수익비율:
-0.0898
EPS:
-16.2673
순현금흐름:
$-9.34M
1주 성능:
+22.69%
1개월 성능:
+19.67%
6개월 성능:
-68.60%
1년 성능:
-89.19%
1일 변동 폭
$1.44
$1.70
1주일 범위
$1.165
$1.84
52주 변동 폭
$1.11
$23.70
Dermata Therapeutics Inc Stock (DRMA) Company Profile
명칭
Dermata Therapeutics Inc
전화
(858)-223-0882
주소
3525 DEL MAR HEIGHTS RD., #322, SAN DIEGO
Compare DRMA vs VRTX, REGN, ALNY, ARGX, INSM
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DRMA
Dermata Therapeutics Inc
|
1.46 | 4.14M | 0 | -8.85M | -9.34M | -16.27 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 115.58B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 79.23B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 43.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 43.26B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 31.97B | 606.42M | -1.28B | -997.58M | -6.403 |
Dermata Therapeutics Inc 주식(DRMA)의 최신 뉴스
Analyst Downgrade: Will Dermata Therapeutics Inc benefit from AI trendsLong Setup & Precise Swing Trade Alerts - baoquankhu1.vn
Risk Recap: Is Dermata Therapeutics Inc Equity Warrant a strong candidate for buy and hold2026 Top Decliners & Comprehensive Market Scan Reports - baoquankhu1.vn
If You Invested $1,000 in Protagenic Therapeutics Inc (PTIX) - Stock Titan
If You Invested $1,000 in THERIVA BIOLOGICS INC (TOVX) - Stock Titan
Valuation Update: Is Dermata Therapeutics Inc. Equity Warrant stock risky to hold now2026 Summary & Safe Entry Point Identification - baoquankhu1.vn
Dermata Therapeutics Poised for Expansion with Strategic Skincare Launch - timothysykes.com
Dermata Therapeutics Strategically Pivots with New Skincare Launch - StocksToTrade
Dermata Therapeutics Strategically Expands into Skincare with Executive Appointment - timothysykes.com
Why Planet Labs Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket - Sahm
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Let's uncover which stocks are experiencing notable gaps during today's session. - ChartMill
Dermata Therapeutics Ramps Up Skincare Division with New VP Appointment - StocksToTrade
Dermata’s Strategic Pivot: New Skincare Line on the Horizon - timothysykes.com
Stay updated with the stocks that are on the move in today's pre-market session. - ChartMill
Dermata Gears Up For First Once-Weekly Acne Kit Launch, Eyeing A Slice Of $3.8B Market - RTTNews
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Get insights into the top gainers and losers of Thursday's after-hours session. - ChartMill
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Published on: 2026-03-20 05:04:24 - baoquankhu1.vn
DRMA Earnings History & Surprises | EPS & Revenue Results | DERMATA THERAPEUTICS INC (NASDAQ:DRMA) - ChartMill
Dermata Therapeutics (DRMAW) Expected to Announce Earnings on Wednesday - Defense World
Dermata Therapeutics (DRMA) SVP adds 1,000 shares in insider buy - Stock Titan
CEO Change: Whats the outlook for Dermata Therapeutics Incs sectorQuarterly Profit Summary & Weekly Watchlist for Consistent Profits - baoquankhu1.vn
Dermata Therapeutics Inc. (DRMA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Dermata Therapeutics Inc expected to post a loss of $1.54 a shareEarnings Preview - TradingView
Dermata Therapeutics names Kyra Peckaitis VP of marketing By Investing.com - Investing.com Canada
Dermata Therapeutics names Kyra Peckaitis VP of marketing - Investing.com Nigeria
Dermata Announces Appointment of Kyra Peckaitis as Vice President, Marketing - lincolnjournal.com
Retail Surge: Is Dermata Therapeutics Inc Equity Warrant a strong candidate for buy and holdJuly 2025 Short Interest & Accurate Intraday Trading Signals - baoquankhu1.vn
Exit Recap: Is Dermata Therapeutics Inc a momentum stockMarket Volume Report & AI Powered Trade Plan Recommendations - baoquankhu1.vn
Dermata Opens a New Chapter with the Release of Tome Skincare - Digital Journal
Dermata Therapeutics Launches Tome Skincare Line to Address Daily Skin Health Needs - geneonline.com
Once‑weekly acne treatment at home: Dermata’s new Tome skincare line - Stock Titan
DRMA SEC FilingsDermata Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan
DRMA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
DRMAWDermata Therapeutics Inc Latest Stock News & Market Updates - Stock Titan
Wall Street Zen Upgrades Dermata Therapeutics (NASDAQ:DRMA) to Hold - Defense World
Dermata Therapeutics Announces Board Resignation and Size Reduction - TipRanks
Board shakeup at Dermata (DRMA) as director Mary Fisher plans exit - Stock Titan
ARMISTICE CAPITAL, LLC Reduces Stake in Dermata Therapeutics Inc - GuruFocus
Update Report: Will Dermata Therapeutics Inc benefit from seasonalityPortfolio Performance Report & Weekly Return Optimization Alerts - baoquankhu1.vn
DRMAW Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Large Dermata (DRMA) holder Gerald Proehl reports 17.3% ownership stake - Stock Titan
Growth Value: What is Dermata Therapeutics Incs valuation compared to sector2025 Winners & Losers & Technical Pattern Alert System - baoquankhu1.vn
Contrasting Qiagen (NYSE:QGEN) & Dermata Therapeutics (NASDAQ:DRMA) - Defense World
Chipmakers Recap: Can Dermata Therapeutics Inc Equity Warrant grow without external fundingJuly 2025 Rallies & Daily Risk Controlled Trade Plans - baoquankhu1.vn
Growth Recap: Is Dermata Therapeutics Inc Equity Warrant benefiting from innovation trendsQuarterly Growth Report & Low Drawdown Trading Techniques - baoquankhu1.vn
Market Movers | Winners: ADVB, KNRX, DRMA | Losers: MBRX, ALIT, DBGI - Trefis
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Armistice Capital, Steven Boyd disclose 4.99% stake in Dermata (DRMA) - Stock Titan
ACXP PE Ratio & Valuation, Is ACXP Overvalued - Intellectia AI
Dermata Therapeutics Inc (DRMA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.82%
자본화:
|
볼륨(24시간):